Cartesian Therapeutics, Inc.
RNAC
$6.36
-$0.30-4.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 125.14M | 143.38M | 160.32M | 180.43M | 212.61M |
| Total Receivables | 1.12M | 722.00K | 354.00K | 1.77M | 872.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.02M | 3.15M | 2.72M | 2.92M | 3.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 129.28M | 147.26M | 163.40M | 185.12M | 216.63M |
|
|
|||||
| Total Current Assets | 129.28M | 147.26M | 163.40M | 185.12M | 216.63M |
| Net Property, Plant & Equipment | 17.79M | 17.37M | 17.45M | 15.53M | 15.45M |
| Long-term Investments | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M |
| Goodwill | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M |
| Total Other Intangibles | 93.90M | 150.60M | 150.60M | 150.60M | 150.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.29M | 7.29M | 7.29M | 7.72M | 2.19M |
| Total Assets | 296.41M | 372.68M | 388.89M | 409.13M | 435.02M |
|
|
|||||
| Total Accounts Payable | 1.29M | 2.23M | 454.00K | 2.10M | 288.00K |
| Total Accrued Expenses | 9.16M | 7.60M | 7.32M | 8.67M | 11.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.15M | 3.88M | 3.79M | 3.70M | 2.85M |
| Total Finance Division Other Current Liabilities | 338.00K | 107.00K | 688.00K | 531.00K | 8.60M |
| Total Other Current Liabilities | 338.00K | 107.00K | 688.00K | 531.00K | 8.60M |
| Total Current Liabilities | 14.94M | 13.80M | 12.26M | 15.00M | 22.98M |
|
|
|||||
| Total Current Liabilities | 14.94M | 13.80M | 12.26M | 15.00M | 22.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.53M | 8.73M | 9.56M | 10.36M | 11.13M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 399.19M | 385.99M | 369.61M | 405.56M | 407.72M |
| Total Liabilities | 422.65M | 408.52M | 391.42M | 430.92M | 441.83M |
|
|
|||||
| Common Stock & APIC | 700.71M | 698.54M | 695.95M | 692.58M | 689.89M |
| Retained Earnings | -822.37M | -729.80M | -693.90M | -709.78M | -692.07M |
| Treasury Stock & Other | -4.58M | -4.59M | -4.58M | -4.59M | -4.62M |
| Total Common Equity | -126.24M | -35.84M | -2.53M | -21.79M | -6.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -126.24M | -35.84M | -2.53M | -21.79M | -6.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -126.24M | -35.84M | -2.53M | -21.79M | -6.80M |
|
|
|||||